Correlation Between Bio Gene and Oneview Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and Oneview Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Oneview Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and Oneview Healthcare PLC, you can compare the effects of market volatilities on Bio Gene and Oneview Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Oneview Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Oneview Healthcare.

Diversification Opportunities for Bio Gene and Oneview Healthcare

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Bio and Oneview is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Oneview Healthcare PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oneview Healthcare PLC and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Oneview Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oneview Healthcare PLC has no effect on the direction of Bio Gene i.e., Bio Gene and Oneview Healthcare go up and down completely randomly.

Pair Corralation between Bio Gene and Oneview Healthcare

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the Oneview Healthcare. But the stock apears to be less risky and, when comparing its historical volatility, Bio Gene Technology is 1.02 times less risky than Oneview Healthcare. The stock trades about -0.01 of its potential returns per unit of risk. The Oneview Healthcare PLC is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Oneview Healthcare PLC on September 6, 2024 and sell it today you would earn a total of  20.00  from holding Oneview Healthcare PLC or generate 166.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Bio Gene Technology  vs.  Oneview Healthcare PLC

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Oneview Healthcare PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oneview Healthcare PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Oneview Healthcare is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Bio Gene and Oneview Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and Oneview Healthcare

The main advantage of trading using opposite Bio Gene and Oneview Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Oneview Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oneview Healthcare will offset losses from the drop in Oneview Healthcare's long position.
The idea behind Bio Gene Technology and Oneview Healthcare PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine